Anchor lead: One in five women may experience depression after giving birth, and a new drug may help, Elizabeth Tracey reports Brexanolone, marketed as Zulresso, is a newly FDA approved drug for postpartum depression. Lauren Osborne, a postpartum depression expert … <a class="more-link" href="https://podcasts.hopkinsmedicine.org/april-17-2019-brexanolone/"> April 17, 2019 – Brexanolone Read More »</a>

Anchor lead: One in five women may experience depression after giving birth, and a new drug may help, Elizabeth Tracey reports Brexanolone, marketed as Zulresso, is a newly FDA approved drug for postpartum depression. Lauren Osborne, a postpartum depression expert … April 17, 2019 – Brexanolone Read More »

Anchor lead: One in five women may experience depression after giving birth, and a new drug may help, Elizabeth Tracey reports Brexanolone, marketed as Zulresso, is a newly FDA approved drug for postpartum depression. Lauren Osborne, a postpartum depression expert … <a href="https://podcasts.hopkinsmedicine.org/april-17-2019-brexanolone/" rel="noopener noreferrer"> April 17, 2019 – Brexanolone Read More »</a>

Share April 17, 2019 – Brexanolone

Sign up to save your podcasts

April 17, 2019 – Brexanolone

April 17, 2019 – Brexanolone